Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
doi: https://doi.org/10.1101/2020.05.14.20101576
Clémence Basse
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDSarah Diakite
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDVincent Servois
2Department of Radiology, Institut Curie, Paris, France
MDMaxime Frelaut
3Department of Drug Development and Innovation, Institut Curie, Paris & Saint Cloud, France
MDAurélien Noret
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDAudrey Bellesoeur
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDPauline Moreau
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDMarie-Ange Massiani
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDAnne-Sophie Bouyer
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDPerrine Vuagnat
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MDSandra Malak
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDFrançois-Clément Bidard
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MD, PhDDominique Vanjak
5Infectious Diseases Unit, Institut Curie, Paris & Saint Cloud, France
MDIrène Kriegel
6Department of Anesthesia, Intensive Care and Pain Medicine, Institut Curie, Paris & Saint Cloud, France
MDAlexis Burnod
7Supportive and Palliative Care Department, Institut Curie, Paris & Saint-Cloud, France
MDGeoffroy Bilger
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDToulsie Ramtohul
2Department of Radiology, Institut Curie, Paris, France
Gilles Dhonneur
6Department of Anesthesia, Intensive Care and Pain Medicine, Institut Curie, Paris & Saint Cloud, France
MD, PhDCarole Bouleuc
7Supportive and Palliative Care Department, Institut Curie, Paris & Saint-Cloud, France
MDNathalie Cassoux
8Department of Surgical Oncology, Institut Curie, Paris & Saint-Cloud, France
9Université de Paris, Paris, France
MD, PhDXavier Paoletti
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
4UVSQ, Université Paris-Saclay, Saint Cloud, France
MD, PhDLaurence Bozec
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MDPaul Cottu
1Department of Medical Oncology, Institut Curie, Paris & Saint Cloud, France
MD, PhDData Availability
Availability of data and materials The data underlying this article cannot be shared publicly due to current French HIPAA regulations (birthdate, admission date, discharge date, date of death). Data will be shared on reasonable request to the corresponding author.
Posted May 19, 2020.
Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
medRxiv 2020.05.14.20101576; doi: https://doi.org/10.1101/2020.05.14.20101576
Characteristics and outcome of SARS-CoV-2 infection in cancer patients
Clémence Basse, Sarah Diakite, Vincent Servois, Maxime Frelaut, Aurélien Noret, Audrey Bellesoeur, Pauline Moreau, Marie-Ange Massiani, Anne-Sophie Bouyer, Perrine Vuagnat, Sandra Malak, François-Clément Bidard, Dominique Vanjak, Irène Kriegel, Alexis Burnod, Geoffroy Bilger, Toulsie Ramtohul, Gilles Dhonneur, Carole Bouleuc, Nathalie Cassoux, Institut Curie COVID Group, Xavier Paoletti, Laurence Bozec, Paul Cottu
medRxiv 2020.05.14.20101576; doi: https://doi.org/10.1101/2020.05.14.20101576
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (189)
- Cardiovascular Medicine (2834)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12535)
- Forensic Medicine (10)
- Gastroenterology (800)
- Genetic and Genomic Medicine (4413)
- Geriatric Medicine (400)
- Health Economics (712)
- Health Informatics (2842)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4168)
- Nursing (220)
- Nutrition (615)
- Oncology (2195)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (265)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (481)
- Public and Global Health (6754)
- Radiology and Imaging (1485)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (471)
- Toxicology (57)
- Transplantation (200)
- Urology (173)